1. Home
  2. INNV vs NBTX Comparison

INNV vs NBTX Comparison

Compare INNV & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InnovAge Holding Corp.

INNV

InnovAge Holding Corp.

HOLD

Current Price

$9.53

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$29.25

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INNV
NBTX
Founded
2007
2003
Country
United States
France
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
INNV
NBTX
Price
$9.53
$29.25
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$12.00
★ $54.00
AVG Volume (30 Days)
★ 576.2K
141.6K
Earning Date
11-03-2026
09-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 90.91
N/A
EPS
N/A
★ N/A
Revenue
★ $989,707,000.00
N/A
Revenue This Year
$8.51
N/A
Revenue Next Year
$7.99
$50.69
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 15.93
N/A
52 Week Low
$3.94
$14.78
52 Week High
$12.64
$57.14

Technical Indicators

Market Signals
Indicator
INNV
NBTX
Relative Strength Index (RSI) 52.09 54.80
Support Level $7.54 $20.18
Resistance Level $12.05 $35.38
Average True Range (ATR) 0.28 1.51
MACD 0.12 1.10
Stochastic Oscillator 76.37 94.47

Price Performance

Historical Comparison
INNV
NBTX

About INNV InnovAge Holding Corp.

InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: